• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Pfizer Share Price

    Pfizer Share PricePfizer

    Mid Cap 5.3k Result
    ₹4,080.6
    37.1 (0.92%)
    As on 10 December, 2023 | 21:51 BSE: 500680 NSE: PFIZERISIN: INE182A01018

    Pfizer Performance

    Day Range

    • Low 4,050.00
    • High 4,091.05
    ₹ 4,080.6

    52 Week Range

    • Low 3,408.00
    • High 4,560.00
    ₹ 4,080.6
    • Open Price4,050.00
    • Previous Close4,043.50
    • Volume16224

    Start SIP in Pfizer

    Start SIP

    Pfizer Share Price

    • Over 1 Month 3.43%
    • Over 3 Month 6.06%
    • Over 6 Month 2.85%
    • Over 1 Year -9.8%

    Pfizer Key Statistics

    P/E Ratio 35.7
    PEG Ratio -2.4
    Market Cap Cr 18,668
    Price to Book Ratio 5.8
    EPS 131.4
    Dividend 1
    Relative Strength Index 59.85
    Money Flow Index 50.23
    MACD Signal 34.3
    Average True Range 71.42

    Pfizer Investment Rating

    • Master Rating:

    • Pfizer (Nse) has an operating revenue of Rs. 2,300.96 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 34% is great, ROE of 19% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 6% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 2% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Pfizer Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 575531573622637593550
    Operating Expenses Qtr Cr 393421391418406401384
    Operating Profit Qtr Cr 183111182203232192165
    Depreciation Qtr Cr 15162626262734
    Interest Qtr Cr 3334344
    Tax Qtr Cr 523235501041119
    Net Profit Qtr Cr 1499413015131133126
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 2,5262,674
    Operating Expenses Annual Cr 1,6161,775
    Operating Profit Annual in Cr 809836
    Depreciation Cr 106115
    Interest Annual Cr 1310
    Tax Annual Cr 200160
    Net Profit Annual Cr 624613
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 356667
    Cash from Investing Activity Annual Cr -36-575
    Cash from Financing Annual Activity Cr -346-181
    Net Cash Flow Annual Cr -26-88
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 3,2072,864
    Fixed Assets Annual Cr 757870
    Total Non Current Assets Annual Cr 1,4761,504
    Total Current Assets Annual Cr 2,5252,396
    Total Assets Annual Cr 4,0013,901
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 701626
    ROE Annual % 1921
    ROCE Annual % 2426
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3834
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in Pfizer

    Pfizer Technicals

    EMA & SMA

    Current Price
    ₹4,080.6
    37.1 (0.92%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹4,027.73
    • 50 Day
    • ₹3,977.55
    • 100 Day
    • ₹3,939.74
    • 200 Day
    • ₹3,953.82
    • 20 Day
    • ₹4,021.47
    • 50 Day
    • ₹3,967.35
    • 100 Day
    • ₹3,928.52
    • 200 Day
    • ₹3,844.63

    Pfizer Resistance and Support

    PIVOT
    ₹4,073.89
    Resistance
    First Resistance 4,097.77
    Second Resistance 4,114.93
    Third Resistance 4,138.82
    RSI 59.85
    MFI 50.23
    MACD Single Line 34.30
    MACD 33.08
    Support
    First Resistance 4,056.72
    Second Resistance 4,032.83
    Third Resistance 4,015.67

    Pfizer Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 17,838 1,010,344 56.64
    Week 34,905 2,693,952 77.18
    1 Month 21,167 1,255,641 59.32
    6 Month 26,315 1,813,609 68.92

    Pfizer Result Highlights

    Pfizer Synopsis

    NSE-Medical-Diversified

    Pfizer Ltd. is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2424.76 Cr. and Equity Capital is Rs. 45.75 Cr. for the Year ended 31/03/2023. Pfizer Ltd. is a Public Limited Listed company incorporated on 21/11/1950 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1950PLC008311 and registration number is 008311.
    Market Cap 18,668
    Sales 2,301
    Shares in Float 1.65
    No of funds 119
    Yield 0.86
    Book Value 5.82
    U/D Vol ratio 2.4
    LTDebt / Equity
    Alpha -0.05
    Beta 0.32

    Pfizer

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 63.92%63.92%63.92%63.92%
    Mutual Funds 7.39%6.17%5.96%5.97%
    Insurance Companies 7.57%8.68%8.89%8.91%
    Foreign Portfolio Investors 2.82%2.81%2.8%2.77%
    Financial Institutions/ Banks 0.01%0.01%0.01%0.02%
    Individual Investors 13.61%13.68%13.7%13.72%
    Others 4.68%4.73%4.72%4.69%

    Pfizer Management

    Name Designation
    Ms. Meenakshi Nevatia Managing Director
    Mr. Milind Patil Executive Director (Finance) & CFO
    Mr. Samir Kazi Executive Director
    Mr. Sunil Lalbhai Independent Director
    Mr. Pradip Shah Chairman & Ind.Director
    Mr. Uday Khanna Independent Director
    Ms. Meena Ganesh Independent Director

    Pfizer Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Pfizer Corporate Action

    Date Purpose Remarks
    2023-10-28 Quarterly Results
    2023-08-11 Quarterly Results
    2023-05-15 Audited Results & Final Dividend
    2023-02-09 Quarterly Results
    2022-11-11 Quarterly Results
    Date Purpose Remarks
    2023-08-11 FINAL Rs.35.00 per share(350%)Final Dividend
    2023-08-11 SPECIAL Rs.5.00 per share(50%)Special Dividend
    2022-09-20 SPECIAL Rs.30.00 per share (300%) Special Interim Dividend
    2022-08-19 FINAL Rs.35.00 per share(350%)Dividend

    Pfizer MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 41,019
    Nippon India Multi Cap Fund - Growth 22,695
    Aditya Birla Sun Life ELSS Tax Saver Pyt of Inc Dis cum Cap Wdrl 13,536
    SBI Magnum Midcap Fund Regular Growth 13,202
    DSP ELSS Tax Saver Fund Regular Plan Growth 11,693

    Pfizer FAQs

    What is Share Price of Pfizer ?

    Pfizer share price is ₹4,080 As on 10 December, 2023 | 21:37

    What is the Market Cap of Pfizer ?

    The Market Cap of Pfizer is ₹18667.8 Cr As on 10 December, 2023 | 21:37

    What is the P/E ratio of Pfizer ?

    The P/E ratio of Pfizer is 35.7 As on 10 December, 2023 | 21:37

    What is the PB ratio of Pfizer ?

    The PB ratio of Pfizer is 5.8 As on 10 December, 2023 | 21:37

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.